GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stratec SE (OTCPK:SBMDY) » Definitions » Additional Paid-In Capital

Stratec SE (Stratec SE) Additional Paid-In Capital : $39.71 Mil(As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Stratec SE Additional Paid-In Capital?


Stratec SE's quarterly additional paid-in capital increased from Sep. 2023 ($38.42 Mil) to Dec. 2023 ($39.56 Mil) and increased from Dec. 2023 ($39.56 Mil) to Mar. 2024 ($39.71 Mil).

Stratec SE's annual additional paid-in capital increased from Dec. 2021 ($36.40 Mil) to Dec. 2022 ($37.23 Mil) and increased from Dec. 2022 ($37.23 Mil) to Dec. 2023 ($39.56 Mil).

Stratec SE Additional Paid-In Capital Historical Data

The historical data trend for Stratec SE's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stratec SE Additional Paid-In Capital Chart

Stratec SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.40 36.33 36.40 37.23 39.56

Stratec SE Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.93 38.70 38.42 39.56 39.71

Stratec SE Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Stratec SE Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Stratec SE's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Stratec SE (Stratec SE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stratec SE (OTCPK:SBMDY) » Definitions » Additional Paid-In Capital
Comparable Companies
XTER:EUZ XTER:GME ABT SYK BSX MDT XTER:SHL EW SZSE:300760 DXCM ZBH ALGN STE XAMS:PHIA XSWX:SOON SHSE:688271 ASX:COH SWAV BRKR PODD
Traded in Other Exchanges
SBS:Germany
Address
Gewerbestrasse 37, Birkenfeld, RP, DEU, 75217
Website
https://www.stratec.com
Stratec SE designs and manufactures automated analyzer systems for laboratory data management and solutions for molecular diagnostic sample preparation and stabilization. Its business segments are Instrumentation, Diatron and Smart Consumables. Its Instrumentation segment is engaged in designing and manufacturing automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment comprises the business with systems, system components, consumables, and tests in the low throughput hematology and clinical chemistry segment. Its Smart Consumables segment is engaged in developing and selling scientific materials, such as nucleic acid purification. The company generates maximum revenue from the Instrumentation segment.

Stratec SE (Stratec SE) Headlines

From GuruFocus

STRATEC SE: STRATEC Further Expands Its Presence in USA By Acquiring Natech Plastics

By ACCESSWIRE ACCESSWIRE • 06-07-2023